Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31728

1.

Routine use of bilateral internal thoracic artery grafts for left-sided myocardial revascularization in insulin-dependent diabetic patients: early and long-term outcomes.

Gatti G, Soso P, Dell'Angela L, Maschietto L, Dreas L, Benussi B, Luzzati R, Sinagra G, Pappalardo A.

Eur J Cardiothorac Surg. 2014 Sep 19. pii: ezu360. [Epub ahead of print]

PMID:
25239446
[PubMed - as supplied by publisher]
2.

Lessons learned from the use of 1,977 in-situ bilateral internal mammary arteries: a retrospective study.

Mohammadi S, Dagenais F, Voisine P, Dumont E, Baillot R, Doyle D, Charbonneau E, Kalavrouziotis D.

J Cardiothorac Surg. 2014 Sep 20;9(1):158. [Epub ahead of print]

PMID:
25238877
[PubMed - as supplied by publisher]
3.

Validation of the IMS CORE Diabetes Model.

McEwan P, Foos V, Palmer JL, Lamotte M, Lloyd A, Grant D.

Value Health. 2014 Sep;17(6):714-24. doi: 10.1016/j.jval.2014.07.007.

PMID:
25236995
[PubMed - in process]
4.

Pancreatic stone protein/regenerating protein (PSP/reg): a novel secreted protein up-regulated in type 2 diabetes mellitus.

Yang J, Li L, Raptis D, Li X, Li F, Chen B, He J, Graf R, Sun Z.

Endocrine. 2014 Sep 19. [Epub ahead of print]

PMID:
25234740
[PubMed - as supplied by publisher]
5.

Antihyperglycemic Potential of Incretins Orally Delivered via Nano and Microsystems and Subsequent Glucoregulatory Effects.

Araújo F, Shrestha N, Granja PL, Hirvonen J, Santos HA, Sarmento B.

Curr Pharm Biotechnol. 2014 Sep 15. [Epub ahead of print]

PMID:
25219868
[PubMed - as supplied by publisher]
6.

Novel sulfonyl(thio)urea derivatives act efficiently both as insulin secretagogues and as insulinomimetic compounds.

Mascarello A, Silva Frederico MJ, Gomes Castro AJ, Mendes CP, Dutra MF, Woehl VM, Yunes RA, Mena Barreto Silva FR, Nunes RJ.

Eur J Med Chem. 2014 Sep 6;86C:491-501. doi: 10.1016/j.ejmech.2014.09.007. [Epub ahead of print]

PMID:
25203779
[PubMed - as supplied by publisher]
7.

Combined therapy of insulin-producing cells and haematopoietic stem cells offers better diabetic control than only haematopoietic stem cells' infusion for patients with insulin-dependent diabetes.

Dave SD, Trivedi HL, Gopal SC, Chandra T.

BMJ Case Rep. 2014 Sep 8;2014. pii: bcr2013201238. doi: 10.1136/bcr-2013-201238.

PMID:
25199184
[PubMed - in process]
8.

The GIP Receptor Displays Higher Basal Activity than the GLP-1 Receptor but Does Not Recruit GRK2 or Arrestin3 Effectively.

Al-Sabah S, Al-Fulaij M, Shaaban G, Ahmed HA, Mann RJ, Donnelly D, Bünemann M, Krasel C.

PLoS One. 2014 Sep 5;9(9):e106890. doi: 10.1371/journal.pone.0106890. eCollection 2014.

PMID:
25191754
[PubMed - in process]
Free PMC Article
9.

Type 2 diabetes: is pancreas transplantation an option?

Ciancio G, Burke GW.

Curr Diab Rep. 2014 Nov;14(11):542. doi: 10.1007/s11892-014-0542-9.

PMID:
25189435
[PubMed - in process]
10.

Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis.

Al-Badri MR, Azar ST.

Ther Adv Endocrinol Metab. 2014 Apr;5(2):34-8. doi: 10.1177/2042018814543483. Review.

PMID:
25152810
[PubMed]
Free PMC Article
11.

Apolipoprotein A-I Increases Insulin Secretion and Production From Pancreatic β-Cells via a G-Protein-cAMP-PKA-FoxO1-Dependent Mechanism.

Cochran BJ, Bisoendial RJ, Hou L, Glaros EN, Rossy J, Thomas SR, Barter PJ, Rye KA.

Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2261-7. doi: 10.1161/ATVBAHA.114.304131. Epub 2014 Aug 21.

PMID:
25147338
[PubMed - in process]
12.

A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications.

Alcubierre N, Rubinat E, Traveset A, Martinez-Alonso M, Hernandez M, Jurjo C, Mauricio D.

Health Qual Life Outcomes. 2014 Aug 20;12(1):131. doi: 10.1186/s12955-014-0131-2.

PMID:
25138117
[PubMed - in process]
Free Article
13.

[The cultural history of the discovery of insulin].

Felkai P.

Lege Artis Med. 2014 Apr;24(4):222-8. Hungarian. No abstract available.

PMID:
25137765
[PubMed - indexed for MEDLINE]
14.

Synthesis, in vitro and in silico studies of a PPARγ and GLUT-4 modulator with hypoglycemic effect.

Navarrete-Vázquez G, Torres-Gómez H, Hidalgo-Figueroa S, Ramírez-Espinosa JJ, Estrada-Soto S, Medina-Franco JL, León-Rivera I, Alarcón-Aguilar FJ, Almanza-Pérez JC.

Bioorg Med Chem Lett. 2014 Sep 15;24(18):4575-9. doi: 10.1016/j.bmcl.2014.07.068. Epub 2014 Aug 1.

PMID:
25131539
[PubMed - in process]
15.

Xenograft of microencapsulated sertoli cells for the cell therapy of type 2 diabetes mellitus in spontaneously diabetic nonhuman primates: preliminary data.

Luca G, Cameron DF, Arato I, Mancuso F, Linden EH, Calvitti M, Falabella G, Szekeres K, Bodo M, Ricci G, Hansen BC, Calafiore R.

Transplant Proc. 2014 Jul-Aug;46(6):1999-2001. doi: 10.1016/j.transproceed.2014.06.053.

PMID:
25131093
[PubMed - in process]
16.

Metabolic surgery for the treatment of type 2 diabetes in pancreas after kidney transplant candidates.

Gullo-Neto S, Vontobel Padoin A, Queiroz de Carvalho JE, Wendling R, Traesel MA, Kroth L, Miranda C, Balestro AC, Siqueira R, Chao Lisot B, Lima S, Corá Mottin C, Saitovitch D.

Transplant Proc. 2014 Jul-Aug;46(6):1741-4. doi: 10.1016/j.transproceed.2014.05.005.

PMID:
25131025
[PubMed - in process]
17.

Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus.

Pipi E, Marketou M, Tsirogianni A.

World J Diabetes. 2014 Aug 15;5(4):505-10. doi: 10.4239/wjd.v5.i4.505. Review.

PMID:
25126396
[PubMed]
Free PMC Article
18.

Cross-talk between SIRT1 and endocrine factors: effects on energy homeostasis.

Quiñones M, Al-Massadi O, Fernø J, Nogueiras R.

Mol Cell Endocrinol. 2014 Aug 7. pii: S0303-7207(14)00236-6. doi: 10.1016/j.mce.2014.08.002. [Epub ahead of print]

PMID:
25109279
[PubMed - as supplied by publisher]
19.

Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus.

Kolodka T, Charles ML, Raghavan A, Radichev IA, Amatya C, Ellefson J, Savinov AY, Nag A, Williams MS, Robbins MS.

PLoS One. 2014 Aug 6;9(8):e103981. doi: 10.1371/journal.pone.0103981. eCollection 2014.

PMID:
25100328
[PubMed - in process]
Free PMC Article
20.

[Evaluation of the effectiveness of Ganfort treatment in patients with secondary neovascular glaucoma associated with diabetes mellitus].

Lipatov DV, Chistiakov TA, Kuz'min AG, Tolkacheva AA.

Vestn Oftalmol. 2014 May-Jun;130(3):45-8. Russian.

PMID:
25098122
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk